These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25364678)

  • 1. Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism.
    Paydas S; Acikalim A; Kaya B; Bicer BH; Ulker M; Demircan O; Uguz A; Balal M; Sakman G; Sertdemir Y; Karaer R; Altun E
    Indian J Endocrinol Metab; 2014 Nov; 18(6):826-30. PubMed ID: 25364678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Brown A; Dusso A
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S54-7. PubMed ID: 11158862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism.
    Gogusev J; Duchambon P; Stoermann-Chopard C; Giovannini M; Sarfati E; Drüeke TB
    Nephrol Dial Transplant; 1996 Nov; 11(11):2155-62. PubMed ID: 8941573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
    Dusso A; Cozzolino M; Lu Y; Sato T; Slatopolsky E
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):507-11. PubMed ID: 15225829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
    Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids.
    Ricci F; Mingazzini PL; Sebastiani V; D'Erasmo E; Letizia C; De Toma G; Alò PL
    Ann Diagn Pathol; 2002 Aug; 6(4):229-35. PubMed ID: 12170454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth.
    Dusso AS; Pavlopoulos T; Naumovich L; Lu Y; Finch J; Brown AJ; Morrissey J; Slatopolsky E
    Kidney Int; 2001 Mar; 59(3):855-65. PubMed ID: 11231340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
    Arcidiacono MV; Sato T; Alvarez-Hernandez D; Yang J; Tokumoto M; Gonzalez-Suarez I; Lu Y; Tominaga Y; Cannata-Andia J; Slatopolsky E; Dusso AS
    J Am Soc Nephrol; 2008 Feb; 19(2):310-20. PubMed ID: 18216322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study.
    Sadler GP; Morgan JM; Jasani B; Douglas-Jones A; Wheeler MH
    World J Surg; 1996 Sep; 20(7):736-42; discussion 742-3. PubMed ID: 8678944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
    Buchwald PC; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia.
    Arcidiacono MV; Cozzolino M; Brancaccio D; Gallieni M; Lesma E; Carelli S; Gorio A; Di Giulio AM
    J Nephrol; 2007; 20(2):228-33. PubMed ID: 17514628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.
    Cozzolino M; Lu Y; Finch J; Slatopolsky E; Dusso AS
    Kidney Int; 2001 Dec; 60(6):2109-17. PubMed ID: 11737585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms for parathyroid hyperplasia.
    Dusso AS; Sato T; Arcidiacono MV; Alvarez-Hernandez D; Yang J; Gonzalez-Suarez I; Tominaga Y; Slatopolsky E
    Kidney Int Suppl; 2006 Jul; (102):S8-11. PubMed ID: 16810310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H; Iida M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii9-12. PubMed ID: 12771291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously].
    Itoh K; Tanaka M; Matsushita K; Tominaga Y
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):706-12. PubMed ID: 14631767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1.
    Skarpen E; Johannessen LE; Bjerk K; Fasteng H; Guren TK; Lindeman B; Thoresen GH; Christoffersen T; Stang E; Huitfeldt HS; Madshus IH
    Exp Cell Res; 1998 Aug; 243(1):161-72. PubMed ID: 9716460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
    Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
    Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease.
    Cozzolino M; Lu Y; Sato T; Yang J; Suarez IG; Brancaccio D; Slatopolsky E; Dusso AS
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1096-102. PubMed ID: 15998841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.